The Era of AI Agents Doing the Work Has Officially Arrived
Merck just made a $1 billion bet. Here’s what it means for every enterprise, and why the window to act is closing.
Merck just partnered with Google Cloud in a $1 billion deal to deploy AI Agents across their entire global business. 75,000+ employees. Multi-year commitment.
Not a pilot. Not a demo. Full deployment.
Autonomous agents working alongside scientists to discover drugs faster, optimize supply chains in real-time, and run operations at a scale no human team could match alone.
This is what it looks like when an enterprise stops exploring AI and starts betting on it
For years, the dominant enterprise AI story was cautious. Proof of concepts. Sandboxed pilots. Innovation committees. A lot of PowerPoints about “the future of work.”
Merck’s move is categorically different. This is infrastructure-level commitment — the kind of decision that restructures how an entire organization operates. When a company of this size deploys AI Agents as a “digital backbone,” they’re not augmenting their workflows. They’re rebuilding them.
That’s the shift most organizations are still underestimating.
“The companies pulling ahead right now aren’t smarter or better funded. They made one decision differently.”
What we’re seeing on the ground at Saasberry
We build enterprise AI Agents. We work with teams across industries trying to make the leap from “AI experiment” to “AI infrastructure.” And the pattern we see over and over is this:
The companies winning right now aren’t smarter or better funded than the ones still waiting. They made one decision differently, they stopped treating AI Agents as a tool and started treating them as part of the team.
That mindset shift sounds simple. It isn’t. It requires rethinking how work gets assigned, how decisions get made, and how humans and systems collaborate. But the organizations that have made it are already operating at a different level, and the gap is widening every quarter.
The window is not closing, it’s already closing
There’s a version of this story where most enterprises read about Merck and think: “Interesting. We should look into that.” And then they schedule a meeting about it. And then six months pass.
That’s the trap. Because the companies moving now aren’t just getting a head start — they’re building institutional knowledge, refining agent workflows, and creating compounding advantages that are very hard to replicate once they’re established.
Merck isn’t doing this to experiment. They’re doing this to make their current competitors structurally irrelevant within a decade.
The question every enterprise leader should be asking right now
Not “should we use AI agents?” That question is already settled.
The real question is: what is the one workflow in your organization that would change everything if an agent owned it?
Start there. Build the proof. Then scale.
SAASBERRY.AI
Saasberry builds enterprise AI Agents for organizations ready to move from experimentation to infrastructure. If that’s you, let’s talk.